Anthocyanins potentiate the activity of trastuzumab in human epidermal growth factor receptor 2positive breast cancer cells in vitro and in vivo

By              

Molecular Medicine Reports, Vol. 10, Iss. 4, 2014-01 ,pp. : 1921-1926

Spandidos Publications

Access to resources Recommend Favorite

Antitumor activity of trastuzumab in combination with chemotherapy in human gastric cancer xenograft models

By Fujimoto-Ouchi Kaori   Sekiguchi Fumiko   Yasuno Hideyuki   Moriya Yoichiro   Mori Kazushige   Tanaka Yutaka  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 6, 2007-06 ,pp. : 795-805

Springer Publishing Company

Access to resources Recommend Favorite

Lapatinib combined with neoadjuvant paclitaxel-trastuzumab-based chemotherapy in patients with human epidermal growth factor receptor 2-positive breast cancer: A meta-analysis of randomized controlled trials

By  

Oncology Letters, Vol. 9, Iss. 3, 2015-01 ,pp. : 1351-1358

Spandidos Publications

Access to resources Recommend Favorite

Factors affecting disease-free survival in patients with human epidermal growth factor receptor 2-positive breast cancer who receive adjuvant trastuzumab

By                      

Molecular and Clinical Oncology, Vol. 3, Iss. 5, 2015-01 ,pp. : 1109-1112

Science Publishers

Access to resources Recommend Favorite

In vitro and in vivo antitumor activity of cetuximab in human gastric cancer cell lines in relation to epidermal growth factor receptor (EGFR) expression and mutational phenotype

By Hotz Birgit   Keilholz Ulrich   Fusi Alberto   Buhr Heinz   Hotz Hubert  

Gastric Cancer, Vol. 15, Iss. 3, 2012-07 ,pp. : 252-264

Springer Publishing Company

Access to resources Recommend Favorite